First human test of a new robotic system for heart artery procedures
Part of Heart & circulation clinical trials.
This trial is testing a new robotic system, R-Star, to help doctors perform minimally invasive procedures to open blocked heart arteries. It may offer a more precise treatment option for people with coronary artery disease who need a stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have coronary artery disease and are scheduled for a planned, non-emergency procedure to open a blocked artery with a stent.
- The artery to be treated has not been treated before, is between 2.5 mm and 4.0 mm wide, and is at least 50% blocked.
- You are willing and able to follow all study requirements, including a 30-day check-up.
- If you are a woman able to have children, you must have a negative pregnancy test within 7 days before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a robotic system to help with a procedure that opens blocked heart arteries. If you need a stent and fit the criteria, you may be able to join.
This trial compares a new, less invasive robotic heart bypass surgery (with stenting) to the standard open-heart bypass surgery. It is for people with multiple blocked heart arteries who are at higher risk for complications from traditional surgery.
This study tests a new kind of coronary stent that slowly releases rapamycin to keep an artery open. You may be invited if you have a small number of specific, treatable blockages and can take the required blood-thinning medicines.
This registry collects real-world information about people having a robotic-assisted heart procedure (PCI) for blocked coronary arteries. It may help doctors understand how well this approach works for different heart conditions.
This trial is comparing two common heart procedures—bypass surgery (CABG) and stents (PCI)—to see which works better for women with blockages in multiple heart arteries. It aims to find the best treatment for women, who are often underrepresented in heart research.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.